Physician profile
Mohit Rastogi
NPI 1518958388
$24,178.57
in general payments reported to CMS, 2019-2025
20 companies · $4,792 in 2025
The $4,792 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,141 · 2020: $3,439 · 2021: $1,880 · 2022: $568 · 2023: $4,054 · 2024: $6,303 · 2025: $4,792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,400 · Travel and Lodging: $3,293 · Food and Beverage: $2,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,400.00 |
| Travel and Lodging | $3,293.08 |
| Food and Beverage | $2,456.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $19,821.98 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Selectra |
| Abbott Laboratories | $1,499.57 | 2019-2025 | Aveir, Ensite, Gallant |
| Medtronic, INC. | $945.87 | 2021-2025 | Azure Xt Dr Mri Surescan, Onyx Frontier, Micra |
| Biosense Webster, INC. | $660.11 | 2019-2025 | Carto 3, Soundstar |
| Atricure, INC. | $192.88 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $152.90 | 2019-2024 | Eliquis |
| Amgen INC. | $143.35 | 2023 | Repatha |
| Vertos Medical, INC. | $129.56 | 2024 | Mild Device Kit |
| Cardiva Medical, INC. | $121.54 | 2021-2025 | Esophageal Cooling Device, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Janssen Pharmaceuticals, INC | $107.20 | 2021-2024 | Xarelto |
| Covidien LP | $102.40 | 2019 | |
| Baxter Healthcare | $76.74 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Pfizer INC. | $48.45 | 2019-2021 | |
| Cvrx, INC. | $46.03 | 2022 | |
| Elutia, INC. | $38.17 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $33.16 | 2022-2024 | |
| Cook Medical LLC | $15.97 | 2019 | |
| Medtronic Vascular, INC. | $15.29 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $14.81 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohit Rastogi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.